Powerful new tools for the treatment of parkinsonism include levodopa, decarboxylase inhibitors, and dopaminergic agonists. Yet earlier drugs still have a useful role to play. The decision to begin pharmacotherapy must be adjusted individually for each patient.
治疗帕金森氏症的强大新工具包括左旋多巴、脱羧酶抑制剂和多巴胺能激动剂。然而，早期的药物仍然有其有用之处。开始药物治疗的决定必须针对每个患者进行个体化调整。
